SCHEMBL2418353

SCHEMBL2418353

C=C(Cc1ccc([N+](=O)[O-])o1)N(CCc1csc(SC(C)(C)C(=O)O)n1)c1cccc(C(C)C)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2414212 0.90 THRA (0.32) —
SCHEMBL2413551 0.84 TUBB4A (0.33) —
SCHEMBL2414109 0.83 STING1 (0.36) —
SCHEMBL2415950 0.82 PPARA (0.33) —
SCHEMBL2410793 0.72 PPARA (0.32) —
SCHEMBL2410789 0.72 PPARA (0.32) —
SCHEMBL2416271 0.70 MAPK14 (0.36) —
SCHEMBL2411454 0.67 PPARA (0.36) —
SCHEMBL2413347 0.64 PPARG (0.38) —
SCHEMBL12274123 0.61 PPARA (0.35) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8026370-B2 Peroxisome proliferator antagonist; hyperlipemia agents; arteriosclerosis; antiischemic agents MITSUBISHI TANABE PHARMA CORPORATION (JP) 2011-09-27 — — US claimed
Send feedback